Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

First-in-human study in Hypercholesterolemia

Trial Profile

First-in-human study in Hypercholesterolemia

Phase of Trial: Phase I

Latest Information Update: 07 Sep 2018

At a glance

  • Drugs NYX 330 (Primary)
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 07 Sep 2018 New trial record
    • 27 Aug 2018 According to Nyrada media release, study expected to take place in 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top